ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ASSADULLAH KAZEMI M.D.

4515 MLK WAY PROVIDENCE ELDERPLACE,

Seattle | Washington | 98108

(206) 320-5325

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,598Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 15

$5,377 Total Retail Price of All Prescriptions

Rank: 14 out of 15

302 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 302 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

7% of this provider’s 302 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

0% of this provider’s 9,522 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$1 was the average price of a prescription from this provider, compared to $38 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 430 375 1 2
SIMVASTATIN 396 339 2 6
VITAMIN D 363 332 10 3 33
OMEPRAZOLE 255 231 4 7
DOK 242 222 5 48
ASPIRIN EC 227 212 6 43
WARFARIN SODIUM 196 169 7 1
SENNA 192 180 8 51
FUROSEMIDE 190 178 9 4
LEVOTHYROXINE SODIUM 184 181 10 3
THERA-TABS M 182 167 10 11 55
METOPROLOL TARTRATE 164 146 12 11
RANITIDINE HCL 163 144 13 22
CITALOPRAM HBR 161 136 14 10
MIRTAZAPINE 152 142 15 21
DONEPEZIL HCL 151 150 16 15
HYDROCHLOROTHIAZIDE 146 138 17 13
MAPAP 144 142 18 53
METFORMIN HCL 140 117 19 16
COUMADIN 136 110 20 83
DIVALPROEX SODIUM 132 121 21 44
NAMENDA 128 128 22 19
AMLODIPINE BESYLATE 127 110 23 9
VITAMIN B-12 117 117 24 73
CALCIUM ANTACID 107 90 10 25 74
ALLOPURINOL 105 94 26 36
GABAPENTIN 105 94 26 12
OXYCODONE HCL 102 88 S2 28 24
HYDROCODONE-ACETAMINOPHEN 101 75 S3 29 5
ATORVASTATIN CALCIUM 98 90 30 18
METOPROLOL SUCCINATE 95 90 31 20
ATENOLOL 88 82 32 23
CARVEDILOL 88 79 32 31
CALCIUM 500 + VIT D 84 84 34 101
TRAZODONE HCL 82 71 35 14
TAMSULOSIN HCL 74 67 36 26
LOSARTAN POTASSIUM 71 68 37 25
CYMBALTA 68 61 38 38
KONSYL 68 52 10 38 117
QUETIAPINE FUMARATE 65 64 40 28
FERROUS SULFATE 65 65 40 122
DIGOXIN 65 65 40 34
LORATADINE 65 65 40 122
LANTUS 64 64 44 27
LAMOTRIGINE 60 37 45 91
FLUOXETINE HCL 58 44 46 67
POTASSIUM CHLORIDE 57 55 47 8
ASPIR-LOW 56 55 48 83
ISOSORBIDE MONONITRATE ER 55 48 49 69
FENTANYL 54 51 S2 50 35
ALENDRONATE SODIUM 53 53 51 46
D3-50 50 48 52 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.